Interventional Cardiology, 2016 (vol. 15), issue 3

Original articles

Interventional in-stent restenosis treatment with usage of dedicated drug coated balloons SeQuent® Please

David Richter, Martin Sluka, David Vindiš, Jiří Ostřanský, Marcela Škvařilová, Miloš Táborský

Interv Akut Kardiol. 2016;15(3):114-118 | DOI: 10.36290/kar.2016.024  

(B. Braun Melsungen AG) – 5-year prospective register with coronarographic controls Aim: Evaluation of the safety and efficacy of interventional in-stent restenosis treatment with usage of dedicated drug coated balloon SeQuent® Please (B.Braun Melsungen AG) in daily interventional practice and comparison of own results with published data. Materials and methods: During 5-year period, between November 2009 and March 2014, 101 consecutive patients (73 males, 28 females, mean age 66.2 years, range 44–90) with number of 122 clinical in-stent restenosis were included in the prospective single-centre register with coronary angiography...

Resynchronization therapy optimization using 3D echocardiography and ECG, comparing response

Jiří Vondrák, Dan Marek, Petr Vojtíšek, Aleš Havlíček, Miloš Táborský

Interv Akut Kardiol. 2016;15(3):120-126 | DOI: 10.36290/kar.2016.025  

immediately after implantation and one month later Aim: The aim of this study is to demonstrate that the setting of the biventricular pacemaker by echocardiography using 3DE will lead to greater hemodynamic response immediately after optimization and creates more reduction of end-systolic volume of left ventricule than the standard setting (according to the width of the QRS complex) in 1 month after implantation. Methods: In this randomized, open-label trial, 63 patients (age 70 ± 10 years, 47 males) indicated for cardiac resynchronization therapy (CRT) have been included. Patients were randomized into two groups. In both groups, the...

Review articles

Bioresorbable vascular scaffolds - Magic of the ephemeral?

Vojtěch Novotný, Ivo Varvařovský, Jan Matějka, Vladimír Rozsíval, Tomáš Lazarák

Interv Akut Kardiol. 2016;15(3):127-134 | DOI: 10.36290/kar.2016.026  

Bioresorbable vascular scaffolds (BVS) represent the most recent substantial change in direction in the field of percutaneous coronary interventions. The idea of temporary scaffolding the vessel and disappearing thereafter is attractive as it can help overcome some of the current metallic drug-eluting stents limitations. The aim of this review article is to situate the technology of BVS in the context of the rapidly evolving domain of coronary interventions, to highlight its potential benefits and pitfalls and to summarize available evidence, both preclinical and clinical. Although many different concepts of BVS are currently in evolution, only those...

Suboptimal stent apposition - treat or leave it?

Tomáš Kovárník, Karel Kopřiva, Štěpán Jeřábek

Interv Akut Kardiol. 2016;15(3):135-139 | DOI: 10.36290/kar.2016.027  

Authors bring an overview of actual knowledge concerning inadequate stent apposition, its causes, possibilities of diagnosis and potential consequences. Main attention is dedicated to techniques of stent malapposition diagnosis. Recommendations are given how to decrease the occurrence of this complication.

Case reports

Cardiac amyloidosis: a case report

František Kováčik, Miloš Táborský, Martin Hutyra, Ondřej Moravec, Jan Přeček

Interv Akut Kardiol. 2016;15(3):145-147 | DOI: 10.36290/kar.2016.029  

This case report describes cardiac symptoms as a dominating feature in the clinical picture of newly diagnosed systemic AL amyloidosis. The definitive diagnosis was confirmed microscopically following endomyocardial biopsy. Subsequently, systemic chemotherapy was initiated as the basic treatment for systemic AL amyloidosis.

Urgent percutaneous coronary intervention of the left main bifurcation stenosis using

Amír Sibai, Lukáš Jaworski, David Horák

Interv Akut Kardiol. 2016;15(3):148-151 | DOI: 10.36290/kar.2016.030  

a dedicated Tryton Side Branch stent in an unstable patient with subacute anterior Q wave myocardial infarction Bifurcation lesions are relatively common coronary angiography findings. Despite the progress in instrumentation and new techniques, their treatment remains technically challenging and time-consuming. It is also associated with worse procedural and long-term clinical outcomes. Dedicated bifurcation stents were developed to simplify the interventional treatment of bifurcation lesions and improve its early and long-term results. In our case report, we present patient with subacute Q wave myocardial infarction of anterior wall, with...

Comments

Commentary on diagnosis of acute aortic dissection - role of D-dimers

Vladimír Svitek, Veronika Jankovičová, Filip Pekar

Interv Akut Kardiol. 2016;15(3):152-154  

Acute aortic dissection represents severe condition with high mortality burden. Early diagnosis is essential to initiate treatment immediately and affect its otherwise sinister prognosis. Diagnostic process could be, due to various reasons, troublesome. Rural health-care services usually dispose of limited diagnostic modalities. CT aortic angiography and/or echocardiography is golden standard in aortic dissection diagnostics. D-dimer test and its role in differential diagnostics of chest pain is less accepted. Examining physician should utilize all range of, however frequently limited, diagnostic tools. Test results should not be interpreted...

Pharmacotherapy

Arterial hypertension and optimal therapy options

Dagmar Vondráková

Interv Akut Kardiol. 2016;15(3):141-144 | DOI: 10.36290/kar.2016.028  

Arterial hypertension is a significant worldwide health problem with the high global prevalence. Although individuals with hypertension have an increased cardiovascular risk, the optimal blood pressure control in these patients remains inadequate. According to the available evidence, the fixed combination of antihypertensive drugs may improve adherence to the therapy and increases achievement of blood pressure targets.


Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.